BOPA Verification Survey

One of BOPA’s work streams for 2019 is to produce a standardised national verification training programme. To help us we need you to tell us about your verification training program.  Please click here to take our survey. or cut and paste link below https://www.surveymonkey.co.uk/r/M9BFVPG 

The survey will take 5 to 10 minutes.    As part of the survey we are asking (optional) for people to share a copy of their Trusts verification training programme.  These will be kept confidential and only used for the standardisation project.  If you are willing to share a copy of your hospitals verification training documentation please email to [email protected].

Thank You
Steve Williamson
BOPA Chair

 

Latest News

By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article
By BOPA Executive Committee on 30th October 2026

Acute and Supportive Oncology Clinical Consensus Statement

BOPA welcomes the Acute and Supportive Oncology Clinical Consensus Statement, to which we were pleased to contribute. It will be a benchmark for the sector, bringing direction and consistency as…

Read article
By BOPA, COSA, CAPhO & ISOPP on 13th October 2026

International Debate Webinar: Eastern and Western Medicine Can Co-exist – part of London Global Cancer Week 2026

Monday 2 November 2026 | 21:00 GMT (check your local time) Part of London Global Cancer Week 2026 Can Eastern and Western medicine co-exist in modern cancer care? Or do…

Read article
By Joseph Williams on 8th October 2026

BOPA 2026 Mentioned in Pharmaceutical Journal

Invest in aseptic services for future of specialised medicines, says chief pharmacist – The Pharmaceutical Journal Aseptic facilities are “absolutely essential” for hospitals to be involved in clinical trials and…

Read article